Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • SPOTLIGHT

Swedish science bounces back

The country’s science sector took drug-firm shutdowns hard, but has diversified and is on the up.
By
  1. Nic Fleming

    1. Nic Fleming is a freelance writer based in Bristol, UK.

Photograph of varied and colourful buildings by the water in Stockholm.

Stockholm is home to several entrepreneurial companies that are reshaping Sweden’s scientific industry. Credit: Domingo Leiva/Getty Images

Mergers, acquisitions and restructuring are par for the course in the pharmaceutical industry. Markets grow and shrink, new treatments are developed and corporate priorities change. Jobs are created, moved and lost. This came as no comfort to the 600 people left out of work when AstraZeneca shut down its research facility in Lund, Sweden, in 2011. As the ripples spread, some saw it as the latest in a series of blows signalling the death of a local industry.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Learn more

Prices may be subject to local taxes which are calculated during checkout

Nature 555, S69-S70 (2018)

doi: https://doi.org/10.1038/d41586-018-03805-1

This article is part of Nature Spotlight: Sweden & Medicon Valley, an editorially independent supplement produced with the financial support of third parties. About this content.

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links